Back to Search
LEE NADLER, M.D.
M.D.
Medical Oncology Physician
NPI: 1821170564IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
40927(MA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1973
Research & Publications (20)
Lee Marshall Nadler, MD: a conversation with the editor.
PMID 17948113·Proc (Bayl Univ Med Cent)·2007
8-other
From genomics to cancer vaccines: patient-tailored or universal vaccines?
PMID 12596359·Curr Opin Mol Ther·2002
6-review
Identification of a basolateral sorting signal for the M3 muscarinic acetylcholine receptor in Madin-Darby canine kidney cells.
PMID 11136723·J Biol Chem·2001
7-preclinical
Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.
PMID 18596736·Leukemia·2009
8-other
Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.
PMID 18927298·Clin Cancer Res·2008
8-other
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.
PMID 18765557·Clin Cancer Res·2008
3-trial
Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.
PMID 18813111·Transplantation·2008
8-other
Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies.
PMID 18617635·Blood·2008
3-trial
Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells.
PMID 18641323·J Immunol·2008
7-preclinical
High-throughput gene expression profiling of memory differentiation in primary human T cells.
PMID 18673556·BMC Immunol·2008
8-other
Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.
PMID 18829491·Clin Cancer Res·2008
8-other
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
PMID 17515573·J Clin Oncol·2007
8-other
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
PMID 17697968·Biol Blood Marrow Transplant·2007
3-trial
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
PMID 17363542·Clin Cancer Res·2007
8-other
Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses.
PMID 16707591·Clin Cancer Res·2006
8-other
CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.
PMID 16357329·Blood·2006
8-other
Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.
PMID 16647567·Exp Hematol·2006
7-preclinical
Rapid, reliable and inexpensive quality assessment of biotinylated cRNA.
PMID 16648895·Braz J Med Biol Res·2006
4-observational
Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia.
PMID 16778141·Blood·2006
8-other
Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity.
PMID 16239433·Blood·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, SMITH BUILDING, SUITE 339
BOSTON, MA 02115 - Phone
- (617) 632-3331
Quick Facts
- NPI
- 1821170564
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 53
- Publications
- 20
Are you this provider?
Claim Your Profile